Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B

Date
2015
Author
Arslan, S.
Dogan, Z.
Kucukazman, M.
Poyrazoglu, O. K.
Biyik, M.
Ozturk, N. A.
Aydogan, T.
Coban, S.
Kocaman, O.
Sapmaz, F.
Gokturk, S. H.
Demirezer, A.
Tanoglu, A.
Yildirim, B.
Altinbas, A.
Atak, B. M.
Cosar, A. M.
Alkan, E.
KOÇAK TUFAN, ZELİHA
Kekilli, M.
Ataseven, H.
Purnak, T.
Basar, O.
Koklu, N.
Ozturk, O.
Karaca, C.
Besisik, F.
Unverdi, S.
Guner, R.
Bakkaloglu, K.
Koklu, S.
Gulsen, M. T.
Tuna, Y.
Koklu, H.
Yuksel, O.
Demir, M.
Kockar, C.
Metadata
Show full item record
Abstract
BackgroundResults are conflicting with respect to the renal effects of anti-viral agents used for hepatitis B virus infection.
URI
http://hdl.handle.net/20.500.12627/113965
https://doi.org/10.1111/apt.13036
Collections